ECRI Institute today identified surgical stapler misuse as the leading health technology safety concern. In March, the Food and Drug Administration issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. ECRI said other leading health technology risks include: point-of-care ultrasound; sterile processing in medical and dental offices; hemodialysis with central venous catheters; unproven surgical robotic procedures; alarm, alert and notification overload; cybersecurity in the connected home health care environment; missing patient implant data for magnetic resonance imaging; medication dose timing discrepancies in electronic health records; and loose medical device components. 

Related News Articles

Headline
The Joint Commission June 30 announced a new, streamlined process that removes 714 requirements from its hospital accreditation program. The new program,…
Headline
AHA President and CEO Rick Pollack explains how hospitals have made meaningful progress in patient safety and delivering high-quality care, in a column…
Headline
A 60-day appeal window has passed for the Food and Drug Administration to appeal a federal court ruling that invalidated its final rule to regulate laboratory-…
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at…
Headline
The U.S. District Court for the Eastern District of Texas March 31 ruled that the Food and Drug Administration does not have the authority to regulate…